companydata.dkcompanydata.dk

AGC Biologics A/S: Financial statements 2021

CVR: 25950941

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

AGC Biologics A/S (CVR 25950941) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 2,185,033,000 and a net result of DKK 571,735,000 compared with DKK 278,538,000 the year before. That is an increase of 50.2% compared with the year before. The profit margin was 26.2%. Equity in the 2021 report amounted to DKK 633,585,000. The solvency ratio was 20.2%. The company had 730 employees in the financial year.

Revenue
DKK 2,185,033,000
Gross Profit
DKK 831,905,000
Profit/Loss
DKK 571,735,000
Equity
DKK 633,585,000
Total Assets
DKK 3,140,663,000
Employees
730

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20212.2B831.9M571.7M633.6M730
20201.5B452M278.5M339.7M441
2019996.1M257.1M154.3M215.1M377
2018692.6M162.3M96.2M316.8M312
2017643.6M156.8M74.5M290.6M303

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like AGC Biologics A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

AGC Biologics A/S: The 2020 annual report is outJun 14, 2021

AGC Biologics A/S has published its annual report for 2020. Revenue came to DKK 1,455,071,000, and the net result was DKK 278,538,000.

Tomoko Miyagawa joins the board of AGC Biologics A/SApr 1, 2021

As of April 1, 2021, Tomoko Miyagawa has joined the board of directors of AGC Biologics A/S.

Hideaki Kan leaves the board of AGC Biologics A/SMar 31, 2021

As of March 31, 2021, Hideaki Kan has left the board of directors of AGC Biologics A/S.

About AGC Biologics A/S

AGC Biologics A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2001. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named CMC BIOLOGICS A/S and CMC BIOPHARMACEUTICALS A/S. The management consists of Kasper Møller. The board consists of Tadashi Murano (chair), Alberto Santagostino, Kasper Møller and Mai Iwaya. The company is owned by Asahi Glass Co., Ltd.. The company has 1,503 employees (2026). In 2025, the company reported revenue of DKK 1,959,639,000 and a net result of DKK -328,010,000 compared with DKK -115,005,000 the year before. Equity in the 2025 report amounted to DKK 312,021,000.

Source: annual report 2025, Danish Business Authority